Sanofi India Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi India Limited has submitted a disclosure to the stock exchange under Regulation 30 of the SEBI Listing Regulations. The public filing itself does not specify the exact subject or trigger of the disclosure — only that the company has made a Reg 30-compliant submission. Reg 30 disclosures typically cover material events such as mergers, acquisitions, changes in board or management, debt defaults, or significant contracts. Without further detail in the filing text, the specific event or decision being disclosed cannot be determined.
Until the underlying subject of the Reg 30 disclosure is known, the impact on shareholders or stock price remains unclear. Investors should look for the detailed disclosure document or follow-up announcement from Sanofi India to understand what material event triggered this filing.